We see AMERISE.BO stock slide to 0.50 INR, down 19.35%, in pre-market trade on 05 Mar 2026 on the BSE. Volume was 80,550.00 shares versus an average of 105,411.00, amplifying selling pressure. The stock opened at 0.62 INR and traded between 0.50 INR and 0.67 INR on the prior session. We flag this in our top losers coverage and explain drivers, valuation, and short-term outlook below.

AMERISE.BO stock: pre-market price action

AMERISE.BO stock is quoted at 0.50 INR, reflecting a -19.35% move from the previous close of 0.62 INR. Trading volume ran at 80,550.00 shares, or a relative volume of 0.76, below the 50-day average.

This fall puts the share close to its year low of 0.50 INR, well under the 50-day average price of 0.67 INR and the 200-day average of 0.70 INR.

AMERISE.BO stock: drivers and company update

Amerise Biosciences Ltd. reports no current business activity and lists its industry as Financial – Conglomerates. The company is headquartered in Ahmedabad and lists Albert Hines as CEO. The firm’s IPO date is 2024-12-30.

Investors are reacting to thin fundamentals and low liquidity. The company website and filings show manufacturing of plastic products but limited operating cash flow, which connects directly to the current share weakness.

AMERISE.BO stock: valuation and fundamentals

Key ratios show a mixed picture. Market cap is 33,034,500.00 INR with shares outstanding 66,069,000.00. Reported EPS is 0.01 INR and the trailing P/E is 50.00, while price-to-book is 0.62.

Working capital is negative at -30,352,000.00 INR, cash per share is 0.00 3 INR, and book value per share is 0.81 INR. These metrics explain cautious analyst sentiment and limited margin for error.

AMERISE.BO stock: technicals and volume

Technicals show short-term weakness. RSI is 42.44, CCI is -144.77 indicating oversold conditions, and MACD histogram is slightly negative. Bollinger bands are 0.61–0.83 INR with a middle band at 0.72 INR.

Momentum readings include ROC -22.50% and MFI 32.32, which suggests selling pressure but potential for short-term mean reversion if liquidity improves.

Meyka AI grade and forecast for AMERISE.BO stock

Meyka AI rates AMERISE.BO with a score out of 100: 60.65 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.

Meyka AI’s forecast model projects monthly 0.57 INR, quarterly 0.34 INR, and yearly 0.21 INR. Versus the current price 0.50 INR, that implies a monthly upside of 14.00%, a quarterly downside of -32.00%, and a yearly downside of -57.06%. Forecasts are model-based projections and not guarantees.

AMERISE.BO stock: risks and outlook

Primary risks include negligible operating cash flow, negative working capital, and low liquidity that magnify price moves. The company reports little operational activity, which increases execution risk for any turnaround.

Our price targets: short-term target 0.70 INR if volume returns and fundamentals stabilize, and a cautious 12-month base case 0.25 INR reflecting possible dilution or prolonged inactivity. Adjust strategy to position size and stop-loss when trading thin names.

Final Thoughts

AMERISE.BO stock is a clear pre-market top loser on 05 Mar 2026, trading at 0.50 INR after a -19.35% drop. Weak fundamentals, negative working capital of -30,352,000.00 INR, and low liquidity explain the rapid move. Technicals show oversold readings, which can produce volatile bounces, but fundamentals and sector context in Financial Services remain challenging. Meyka AI’s forecast model projects a monthly price of 0.57 INR (implied upside 14.00%), but longer-term quarterly and yearly projections show downside risks of -32.00% and -57.06% respectively. Our view: limit position size, set tight risk controls, and wait for confirmed volume pickup or corporate updates before increasing exposure. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.